Gilead's coronavirus treatment remdesivir just succeeded in a crucial study, raising hopes for a first COVID-19 drug
Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.
The antiviral drug remdesivir is being tested in several ongoing trials of COVID-19 patients. Gilead stated that one of these studies, run by the US National Institutes of Health, shows the drug works.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Gilead reports 'positive data' on remdesivir coronavirus drug trial
続きを読む »
Gilead reports 'positive data' on remdesivir coronavirus drug trial
続きを読む »
Coronavirus research: flaws in trials for remdesivir, chloroquine - Business Insider'We have no reliable data' on potential coronavirus treatments, one researcher said. Here's how that could change over the next few weeks.
続きを読む »
Coronavirus: EU rewrote coronavirus report after pressure by China - Business InsiderReferences to a Chinese campaign of 'global disinformation' about the coronavirus were removed before publication.
続きを読む »
Coronavirus antibody treatments: Eli Lilly, Regeneron, GSK, Amgen - Business Insider4 top drugmakers are studying the body's own efforts to fight off viruses as they race to find a COVID-19 treatment that could be ready by the fall
続きを読む »
Chanel’s Virginie Viard on the Future: “Truthfulness and Realness Will Be Leading Me Going Forward”.Chanel’s Virginie Viard reflects on the coronavirus crisis and what comes next with Vogue’s Hamish Bowles.
続きを読む »